Beta-O2 Technologies Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Out of Business

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Out of Business

Beta-O2 Technologies General Information

Description

Developer of a bio-artificial pancreas designed to help cure diabetes. The company's device is implantable and provides a viable and safe environment for pancreatic IOL inside a subcutaneously implanted bioreactor which helps the cells to thrive, functioning natively and provides the body with the essential hormones in the correct ratio, and solving the challenges of islet transplantation like adequate oxygen supply by supplying oxygen to contained cells and full immune-protection, enabling patients to be freed from risky and morbidity-inducing immune-suppressive drugs therapy.

Contact Information

Website
www.beta-o2.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 11 Amal Street
  • Post office Box 11793
  • Rosh Haayin 4809900
  • Israel
+972
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Biotechnology
Corporate Office
  • 11 Amal Street
  • Post office Box 11793
  • Rosh Haayin 4809900
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beta-O2 Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 15-Aug-2025 Completed Out of Business
5. Later Stage VC (Series B) 03-Sep-2018 Completed Generating Revenue
4. Later Stage VC 30-Mar-2015 Completed Clinical Trials - Phase 1
3. Grant 10-Sep-2014 Completed Startup
2. Early Stage VC 06-Feb-2007 $5M $7M Completed Startup
1. Seed Round 08-Mar-2004 $2M $2M Completed Startup
To view Beta-O2 Technologies’s complete valuation and funding history, request access »

Beta-O2 Technologies Patents

Beta-O2 Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190125937-A1 Implantable device for implantation of cells having anti-inflammatory and vascularization capabilities and methods of making thereof Inactive 04-Apr-2016
WO-2017175065-A2 Implantable device for implantation of cells having anti-inflammatory and vascularization capabilities and methods of making thereof Inactive 04-Apr-2016
WO-2017175065-A3 Implantable device for implantation of cells having anti-inflammatory and vascularization capabilities and methods of making thereof Inactive 04-Apr-2016
JP-2019501808-A Implantable device for transplantation of cells with anti-inflammatory and angiogenic potential and method for producing the same Pending 04-Apr-2016
JP-2019503828-A System and method for providing oxygen to transplanted cells Pending 08-Feb-2016 A61L27/3804
To view Beta-O2 Technologies’s complete patent history, request access »

Beta-O2 Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Beta-O2 Technologies FAQs

  • When was Beta-O2 Technologies founded?

    Beta-O2 Technologies was founded in 2004.

  • Where is Beta-O2 Technologies headquartered?

    Beta-O2 Technologies is headquartered in Rosh Haayin, Israel.

  • What is the size of Beta-O2 Technologies?

    Beta-O2 Technologies has 15 total employees.

  • What industry is Beta-O2 Technologies in?

    Beta-O2 Technologies’s primary industry is Therapeutic Devices.

  • Is Beta-O2 Technologies a private or public company?

    Beta-O2 Technologies is a Private company.

  • What is Beta-O2 Technologies’s current revenue?

    The current revenue for Beta-O2 Technologies is .

  • How much funding has Beta-O2 Technologies raised over time?

    Beta-O2 Technologies has raised $39.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process